Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Certolizumab pegol is a TNF (tumor necrosis factor) inhibitor that is primarily used to treat Crohn?s disease. Certolizumab pegol is a monoclonal antibody directed against tumor necrosis factor alpha (TNF-alfa). In 2008, it was approved for rheumatoid arthritis treatment under the brand CIMZIA®. It was used off-label to treat psoriatic arthritis until it was approved for this indication in 2013.
The report details the trend, potential and market size of Cimzia (certolizumab) Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cimzia (certolizumab) Drugmarket, defines the market attractiveness level of Cimzia (certolizumab) Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cimzia (certolizumab) Drug industry, describes the types of Cimzia (certolizumab) Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cimzia (certolizumab) Drug market and the development prospects and opportunities of Cimzia (certolizumab) Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cimzia (certolizumab) Drug market in Chapter 13.
By Player:
UCB
By Type:
Crohn's Disease
Rheumatoid Arthritis
By End-User:
Crohn's Disease
Rheumatoid Arthritis
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cimzia (certolizumab) Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cimzia (certolizumab) Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cimzia (certolizumab) Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cimzia (certolizumab) Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cimzia (certolizumab) Drug Market Analysis and Outlook to 2022
-
7.1 Global Cimzia (certolizumab) Drug Consumption (2017-2022)
-
7.2 United States Cimzia (certolizumab) Drug Consumption (2017-2022)
-
7.3 Europe Cimzia (certolizumab) Drug Consumption (2017-2022)
-
7.4 China Cimzia (certolizumab) Drug Consumption (2017-2022)
-
7.5 Japan Cimzia (certolizumab) Drug Consumption (2017-2022)
-
7.6 India Cimzia (certolizumab) Drug Consumption (2017-2022)
-
7.7 South Korea Cimzia (certolizumab) Drug Consumption (2017-2022)
8 Region and Country-wise Cimzia (certolizumab) Drug Market Analysis and Outlook to 2028
-
8.1 Global Cimzia (certolizumab) Drug Consumption Forecast (2022-2028)
-
8.2 United States Cimzia (certolizumab) Drug Consumption Forecast (2022-2028)
-
8.3 Europe Cimzia (certolizumab) Drug Consumption Forecast (2022-2028)
-
8.4 China Cimzia (certolizumab) Drug Consumption Forecast (2022-2028)
-
8.5 Japan Cimzia (certolizumab) Drug Consumption Forecast (2022-2028)
-
8.6 India Cimzia (certolizumab) Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Cimzia (certolizumab) Drug Consumption Forecast (2022-2028)
9 Global Cimzia (certolizumab) Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Cimzia (certolizumab) Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Crohn's Disease Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Rheumatoid Arthritis Consumption and Growth Rate (2017-2022)
-
9.2 Global Cimzia (certolizumab) Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Crohn's Disease Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Rheumatoid Arthritis Consumption and Growth Rate (2017-2022)
10 Global Cimzia (certolizumab) Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Cimzia (certolizumab) Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Crohn's Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Rheumatoid Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cimzia (certolizumab) Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Crohn's Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Rheumatoid Arthritis Consumption Forecast and Growth Rate (2022-2028)
11 Global Cimzia (certolizumab) Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cimzia (certolizumab) Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cimzia (certolizumab) Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cimzia (certolizumab) Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cimzia (certolizumab) Drug Market Competitive Analysis
-
14.1 UCB
-
14.1.1 UCB Company Details
-
14.1.2 UCB Cimzia (certolizumab) Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 UCB Cimzia (certolizumab) Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cimzia (certolizumab) Drug
-
Figure Cimzia (certolizumab) Drug Picture
-
Table Global Cimzia (certolizumab) Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cimzia (certolizumab) Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cimzia (certolizumab) Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cimzia (certolizumab) Drug Consumption by Country (2017-2022)
-
Figure United States Cimzia (certolizumab) Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Cimzia (certolizumab) Drug Consumption and Growth Rate (2017-2022)
-
Figure China Cimzia (certolizumab) Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Cimzia (certolizumab) Drug Consumption and Growth Rate (2017-2022)
-
Figure India Cimzia (certolizumab) Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cimzia (certolizumab) Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Cimzia (certolizumab) Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Cimzia (certolizumab) Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cimzia (certolizumab) Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cimzia (certolizumab) Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cimzia (certolizumab) Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cimzia (certolizumab) Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cimzia (certolizumab) Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Crohn's Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Rheumatoid Arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Crohn's Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Rheumatoid Arthritis Consumption and Growth Rate (2017-2022)
-
Figure Global Crohn's Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rheumatoid Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Crohn's Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rheumatoid Arthritis Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cimzia (certolizumab) Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cimzia (certolizumab) Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table UCB (Foundation Year, Company Profile and etc.)
-
Table UCB Cimzia (certolizumab) Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table UCB Cimzia (certolizumab) Drug Product and Service
-
